GlassScriptPhysician profile
Caroline S Bartelsmeyer
NPI 1477175578
$3,680.93
in general payments reported to CMS, 2019-2025
50 companies · $1,459 in 2025
The $1,459 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $40.69 · 2023: $982 · 2024: $1,199 · 2025: $1,459.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,640.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,640.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $479.03 | 2023-2025 | Piqray, Kisqali |
| Janssen Biotech, INC. | $324.32 | 2023-2025 | Darzalex, Tecvayli, Talvey |
| Regeneron Healthcare Solutions, INC. | $258.83 | 2023-2025 | Libtayo |
| Genentech USA, INC. | $235.47 | 2024-2025 | Tecentriq, Polivy, Alecensa |
| Merck Sharp & Dohme LLC | $234.52 | 2023-2025 | Keytruda, Welireg, Lynparza |
| Takeda Pharmaceuticals U.S.A., INC. | $188.53 | 2023-2025 | Iclusig, Alunbrig, Fruzaqla |
| Astrazeneca Pharmaceuticals LP | $156.49 | 2023-2025 | Calquence, Imfinzi, Enhertu |
| Incyte Corporation | $141.11 | 2023-2025 | Jakafi, Niktimvo, Pemazyre |
| Eisai INC. | $135.22 | 2023-2025 | |
| Daiichi Sankyo INC. | $100.79 | 2023-2025 | Enhertu, Datroway, Injectafer |
| Emmaus Medical, INC. | $85.68 | 2023-2024 | Endari |
| Abbvie INC. | $85.06 | 2024-2025 | |
| Tersera Therapeutics LLC | $68.33 | 2025 | Xermelo, Zoladex |
| Pfizer INC. | $64.44 | 2023-2025 | |
| Sobi, INC | $64.34 | 2023-2025 |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $63.79 | 2023-2025 | |
| Genzyme Corporation | $63.73 | 2022-2024 | |
| Pharmaessentia USA Corporation | $62.13 | 2023-2025 | Besremi |
| Stemline Therapeutics INC. | $62.06 | 2023-2025 | Orserdu |
| Recordati_rare_diseases_inc. | $60.20 | 2025 | Enjaymo |
| Puma Biotechnology, INC. | $58.25 | 2023-2025 | |
| Jazz Pharmaceuticals INC. | $54.08 | 2023-2025 | |
| Menarini Silicon Biosystems, INC. | $45.20 | 2024-2025 | |
| Blueprint Medicines Corporation | $39.88 | 2023-2024 | Ayvakit |
| Exelixis INC. | $38.87 | 2025 | Cabometyx |
| Genmab U.S., INC. | $36.41 | 2023-2024 | Epkinly |
| Myriad Genetic Laboratories, INC. | $27.48 | 2023 | Myrisk |
| Amgen INC. | $27.22 | 2023 | Lumakras, Nplate, Vectibix |
| Adc Therapeutics America, INC. | $25.00 | 2025 | |
| Azurity Pharmaceuticals, INC. | $24.89 | 2025 | Danziten |
| Alexion Pharmaceuticals, INC. | $24.67 | 2025 | Ultomiris |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.06 | 2024 | |
| Lilly USA, LLC | $22.26 | 2024 | Jaypirca |
| G1 Therapeutics, INC. | $22.02 | 2023 | Cosela |
| Angiodynamics, INC. | $21.59 | 2023 | Nanoknife |
| Geron Corporation | $20.84 | 2025 | Rytelo |
| Ethicon US, LLC | $20.70 | 2024 | Echelon; Endopath |
| Optinose US, INC. | $20.34 | 2022 | |
| Glaxosmithkline, LLC. | $19.47 | 2024 | Jemperli, Zejula |
| Mirati Therapeutics, INC. | $18.52 | 2024 | Krazati |
| Corcym INC | $18.41 | 2023 | Mi Detach - Aortic Cross Clamp - Delivery System Kit |
| E.R. Squibb & Sons, L.L.C. | $18.20 | 2024 | Opdivo |
| Kyowa Kirin, INC. | $18.09 | 2023 | Poteligeo |
| Taiho Oncology, INC. | $16.60 | 2025 | |
| Aimmune Therapeutics, INC. | $15.99 | 2025 | Zenpep |
| Pharmacosmos Therapeutics INC. | $15.97 | 2024 | Cosela |
| Sumitomo Pharma America, INC. | $14.26 | 2024 | Orgovyx |
| Coherus Oncology, INC. | $13.48 | 2024 | |
| Hologic Sales and Service, LLC | $13.35 | 2024 | Coolseal Generator |
| Pharmaand Gmbh | $11.76 | 2025 | Rubraca |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Bartelsmeyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.